Volume 7, Issue 4
Editorialp. 357
ADAM17: a potential therapeutic target for rheumatoid arthritis?
Author(s): S Rose-John & A Chalaris
Editorialp. 361
What can be done to maximize adherence of bisphosphonates in patients with osteoporosis?
Author(s): E Rampakakis & JS Sampalis
Brief Reportp. 365
Scientists demonstrate validity of novel rheumatoid arthritis blood test
Author(s): Bulletin Board
Brief Reportp. 366
Open-label Phase II trial of ozoralizumab produces promising results
Author(s): Bulletin Board
Brief Reportp. 366
An epigenetic cause of osteoarthritis has been discovered
Author(s): Bulletin Board
Brief Reportp. 367
Some inflammatory rheumatic disease treatments could increase the patient�s risk of shingles, study suggests
Author(s): Bulletin Board
Brief Reportp. 368
Baricitinib effective in Phase IIb study in treatment of rheumatoid arthritis
Author(s): Bulletin Board
Conceptual Paperp. 369
Odanacatib: a possible new therapeutic option for the treatment of osteoporosis
Author(s): JL Perez-Castrillon, F Pinacho, M Ruiz-Mambrilla & A Duenas Laita
Research Articlep. 377
Disease management in pediatric lupus: could it pose a burden? A Valente, K Badolato, AL Hassett,
Author(s): MA Rapoff, MGE Peterson, D Pineles, TJA Lehman & LN Moorthy
Research Articlep. 383
Long-term safety of rituximab in patients with rheumatoid arthritis
Author(s): E Becerra, G Cambridge, I de la Torre & MJ Leandro
Short Reportp. 391
Clinical and imaging assessment of peripheral enthesitis in ankylosing spondylitis
Author(s): A Spadaro, FM Perrotta, A Carboni & A Scarno
Short Reportp. 397
Platelet-rich plasma injections for tendinopathy and osteoarthritis
Author(s): I Andia & M Abate
Review Articlep. 413
Promise and pitfalls of kinase inhibitors for rheumatoid arthritis
Author(s): S Cohen
Review Articlep. 425
Safety of biologics in rheumatoid arthritis
Author(s): SC Horton, JL Nam & MH Buch
Review Articlep. 453
Treatment of osteoporosis in patient with chronic kidney disease
Author(s): SL West & SA Jamal
